Financial Results For The Quarter And Nine Months Ended December 31, 2017
the Board of Directors of the Company at its meeting held today (February 13, 2018) had Approved the Un-audited Financial Results for the quarter and nine months ended December 31, 2017, as recommended by the audit committee at its meeting held today. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP , Chartered Accountants, Statutory Auditors of the Company is enclosed Board Meeting-Outcome of Board Meeting
the Board of Directors of the Company at its meeting held today (February 13, 2018) had inter-alia: Approved the Un-audited Financial Results for the quarter and nine months ended December 31, 2017, as recommended by the audit committee at its meeting held today. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP , Chartered Accountants, Statutory Auditors of the Company is enclosed;... What to Watch: 200 cos will declare results on Tuesday
With this quarter's results season approaching its end, close to 200 companies are set to announce their results on Tuesday. Among these are Amrutanjan, Board to consider Dividend
A meeting of the Board of Directors is scheduled to be held on Tuesday, February 13, 2018 at the registered office of the Company to consider and approve the Declaration of Second Interim Dividend for the financial year 2017-18 Intimation of Sub division / Stock Split
A meeting of the Board of Directors is scheduled to be held on Tuesday, February 13, 2018 at the registered office of the Company to consider and approve the Sub- division of equity shares of face value of Rs. 2/- each Board to consider Second Interim Dividend & Sub-division of equity shares
Amrutanjan Health Care Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on February 13, 2018, inter alia, to consider and approve the following:1. Sub- division of equity shares of face value of Rs. 2/- each.2. Un-audited Financial Results along with the Limited Review Report for the quarter and nine months ended December 31, 2017.... Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and as per Company's Code of Conduct to regulate, monitor and report trading by insiders, the trading window for dealing in the securities of the Company shall remain closed for the Specified Persons (Promoters, Directors, Designated Employees, etc) from Friday, January 26, 2018 to Thursday, February 15, 2018 (both days inclusive) for the purpose of meeting of the Board of Directors... Board Meeting On February 13, 2018
A meeting of the Board of Directors is scheduled to be held on Tuesday, February 13, 2018 at the registered office of the Company to consider and approve, inter-alia, the : a)Sub- division of equity shares of face value of Rs. 2/- each b)Un-audited Financial Results along with the Limited Review Report for the quarter and nine months ended December 31, 2017.... Shareholding for the Period Ended December 31, 2017
Amrutanjan Health Care Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended 31St December, 2017.
statement of Investor Complaints for the Quarter ended 31st December, 2017.